INOVA Diagnostics Launches BIO-FLASH, A Rapid-Response Chemiluminescent Analyzer

INOVA Diagnostics is pleased to announce the full commercial launch of BIO-FLASH, a rapid-response chemiluminescent analyzer for use by clinical reference and hospital laboratories. This signals the global release of BIO-FLASH along with QUANTA Flash reagents for autoimmune disease diagnostic testing.

BIO-FLASH is a technologically advanced analyzer which offers full automation of a broad menu of highly accurate QUANTA Flash immunoassays for autoimmunity testing. Tests that previously required significant hands on time can now be automated on an intuitive and rapid system with BIO-FLASH. BIO-FLASH and the QUANTA Flash reagents are classified as moderately complex under the Clinical Laboratories Improvements Act (CLIA), making the system accessible to a wide range of laboratories and their staff. The first result is generated in as little as 30 minutes, with additional results generated one per minute thereafter.

BIO-FLASH incorporates chemiluminescent technology, representing an important advance in accuracy and precision for immunoassay testing. Other benefits of the BIO-FLASH system include an increased analytical measuring range, onboard dilution and stored calibration. A comprehensive menu of QUANTA Flash reagents is available today, including tests to aid in the diagnosis of Celiac Disease, Vasculitis, Antiphospholipid Syndrome and Connective Tissue Diseases. This menu will continue to expand as INOVA develops additional autoimmune assays that fully leverage the many advantages of BIO-FLASH.

BIO-FLASH has been well received by hospitals and clinical reference laboratories. Dr. Marvin Fritzler, whose laboratory at the University of Calgary uses BIO-FLASH, commented, "BIO-FLASH has dramatically enhanced the workflow and decreased turnaround times for autoantibody testing at our facility. The user-friendly interface allows rapid adoption by laboratory staff members. We are looking forward to an expanding catalogue of immunoassays developed by INOVA."